心臟結構器材市場規模、佔有率、成長分析、按產品、按程序、按地區 - 產業預測，2024-2031 年

Structural Heart Devices Market Size, Share, Growth Analysis, By Product, By Procedure, By Region - Industry Forecast 2024-2031

出版日期: 2024年10月03日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年心臟結構器材市場規模將為109.7億美元，從2023年的119.7億美元成長到2031年的245.8億美元，預測期間（2024-2031年）複合年成長率為9.4%

全球結構性心臟器械市場在幾個關鍵因素的推動下出現強勁成長，包括結構性心臟病發病率上升、微創手術技術的進步以及人口老化的擴大。隨著心血管疾病盛行率的增加，對心臟結構裝置的需求只會持續增加，進一步推動創新治療方案的採用。該市場得到了對技術先進設備的大力推動以及對研發的大量投資的支持，凸顯了該領域創新的重要性。然而，這些設備的高成本和嚴格的監管障礙等挑戰可能會阻礙成長。儘管存在這些障礙，但在心臟結構治療設備技術的持續進步以及對以患者為中心的循環系統醫學護理日益濃厚的興趣的支持下，市場預計將保持上升勢頭。特別是，美國心臟結構器材市場預計將持續成長，預計在預測期內將保持穩定的年複合成長率（CAGR）。這一趨勢凸顯了醫療保健產業致力於透過增強結構性心臟病領域的治療選擇和最尖端科技解決方案來改善患者的治療結果。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Boston Scientific Corporation
Medtronic
Edwards Lifesciences Corporation
Abbott Laboratories
Biomerics
Teleflex Incorporated
LivaNova PLC
JenaValve Technology, Inc.
CardioKinetix
Lepu Medical Technology
CryoLife
Micro Interventional Devices
Braile Biomedica
TTK Healthcare（A TTK Group Company）

簡介目錄

Product Code: SQMIG35G2184

Structural Heart Devices Market size was valued at USD 10.97 billion in 2022 and is poised to grow from USD 11.97 billion in 2023 to USD 24.58 billion by 2031, growing at a CAGR of 9.4% in the forecast period (2024-2031)

The global structural heart devices market is experiencing robust growth, fueled by several key factors, including the rising incidence of structural heart diseases, advancements in minimally invasive surgical techniques, and an expanding aging demographic. As the prevalence of cardiovascular conditions escalates, the demand for structural heart devices continues to increase, further driving the adoption of innovative treatment options. The market is bolstered by a strong push for technologically advanced devices and significant investments in research and development, highlighting the importance of innovation in this sector. However, challenges such as the high costs of these devices and strict regulatory hurdles could hinder growth. Despite these obstacles, the market is anticipated to maintain its upward trajectory, supported by continuous advancements in structural heart device technology and a heightened focus on patient-centered care within cardiology. In particular, the U.S. structural heart devices market is well-positioned for sustainable growth, with expectations for a steady compound annual growth rate (CAGR) in the upcoming forecast period. This trend underscores the healthcare industry's commitment to improving patient outcomes through enhanced treatment options and cutting-edge technological solutions in the realm of structural heart diseases.

Top-down and bottom-up approaches were used to estimate and validate the size of the Structural Heart Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Structural Heart Devices Market Segmental Analysis

Global Structural Heart Devices Market is segmented by Product, Procedure, and region. Based on Product, the market is segmented into Heart Valve Devices (Transcatheter Heart Valves, Surgical Heart Valves (Tissue Heart Valves, Mechanical Heart Valves)), Occluders & Delivery Systems, Annuloplasty Rings, Accessories, and Other Devices. Based on Procedure, the market is segmented into Replacement Procedures (TAVR Procedures, Savr Procedures), Repair Procedures (Closure Procedures, Annuloplasty, Valvuloplasty, TMVR Procedures). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Structural Heart Devices Market

The global structural heart devices market is significantly driven by the rising prevalence of structural heart diseases, including heart valve disorders and congenital abnormalities, which necessitate advanced treatment options. As the incidence of these conditions escalates, the demand for specialized devices has surged. Furthermore, technological advancements in minimally invasive procedures have enhanced patient outcomes, making treatments more accessible and effective. Coupled with the increasing geriatric population, which is particularly vulnerable to these ailments, the market continues to expand. This growing demographic shift and innovation in medical devices create a robust environment for the structural heart devices market's growth and evolution.

Restraints in the Structural Heart Devices Market

The global structural heart devices market faces a significant restraint due to the high costs associated with these advanced medical devices and their implantation procedures. The expense encompasses not only the devices themselves but also the comprehensive costs of development, clinical trials, and adherence to regulatory standards, which can place a financial strain on both patients and healthcare systems. In particular, developing regions may experience limited accessibility and affordability, further curtailing market penetration. Additionally, price sensitivity among consumers and restricted insurance coverage in certain markets can impede the widespread adoption of structural heart devices, ultimately stunting the overall growth of the market.

Market Trends of the Structural Heart Devices Market

A prominent trend in the global structural heart devices market is the surge in minimally invasive procedures, exemplified by transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR). These innovative techniques are increasingly favored for their substantial advantages, including shorter hospital stays, expedited recovery times, and diminished complications compared to conventional open-heart surgeries. This growth is propelled by continuous advancements in medical technology that enhance procedural precision and efficacy. As healthcare providers and patients alike recognize the benefits of these less invasive options, the demand for structural heart devices is expected to rise steadily, shaping the market's future landscape.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Regulatory Analysis
Case Study Analysis
Market Attractiveness Index
Supply Chain Analysis
Customer & Buying Criteria Analysis

Structural Heart Devices Market, By Product

Market Overview
Heart Valve Devices
- Transcatheter Heart Valves
- Surgical Heart Valves
- Tissue Heart Valves
- Mechanical Heart Valves
Occluders & Delivery Systems
Annuloplasty Rings
Accessories
Other Devices

Structural Heart Devices Market, By Procedure

Replacement Procedures
Tavr Procedures
Savr Procedures
Repair Procedures
Closure Procedures
Annuloplasty
Valvuloplasty
Tmvr Procedures

Structural Heart Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edwards Lifesciences Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomerics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
JenaValve Technology, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CardioKinetix
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lepu Medical Technology
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CryoLife
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Micro Interventional Devices
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Braile Biomedica
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TTK Healthcare (A TTK Group Company)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments